Stereotaxis (STXS) EBT Margin (2010 - 2026)

Stereotaxis' (STXS) quarterly EBT Margin came in at 203.12% in Q1 2026, down 11983.0% year-on-year from N/an in Q1 2025, and down 152.06% on a QoQ basis from 80.58% in Q4 2025.

Stereotaxis (STXS) EBT Margin (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has 17 years of EBT Margin data on file, last reported at 203.12% in Q1 2026.

  • On a quarterly basis, EBT Margin fell 11983.0% year-over-year to 203.12% in Q1 2026; TTM through Mar 2026 was 104.05%, a 315.0% decrease from a year earlier, with the FY2025 full-year figure at 75.09%, up 16115.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 203.12%, down from 80.58% in the prior quarter.
  • Over the last five years, EBT Margin for STXS reached as high as 64.27% in Q1 2022 and fell as low as 203.12% in Q1 2026.
  • Historically, EBT Margin has averaged 93.43% across 5 years, with a median of 80.58% in 2025.
  • Across the five-year window, EBT Margin jumped 7274 bps in 2025 and sank 11983 bps in 2026, its largest moves.
  • Year by year, EBT Margin stood at 64.32% in 2022, then slumped by 89 bps to 121.86% in 2023, then slipped by 12 bps to 136.12% in 2024, then soared by 41 bps to 80.58% in 2025, then plunged by 152 bps to 203.12% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 203.12% in Q1 2026, 80.58% in Q4 2025, and 91.84% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 8.94%
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 36.46%
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 0.83%
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 3.96%
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 35.09%
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 20.65%
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -4.48%
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 0.80%
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 14.31%
10 Stereotaxis 136.49 Mn 121.87 Mn 3.79 Mn -203.12%

Historic Data

Download Data
DateValue
Mar 31, 2026 -203.12%
Dec 31, 2025 -80.58%
Sep 30, 2025 -91.84%
Jun 30, 2025 -66.62%
Mar 31, 2025 -83.28%
Dec 31, 2024 -136.12%
Sep 30, 2024 -72.11%
Jun 30, 2024 -139.36%
Mar 31, 2024 -72.73%
Dec 31, 2023 -121.86%
Sep 30, 2023 -75.57%
Jun 30, 2023 -70.26%
Mar 31, 2023 -89.51%
Dec 31, 2022 -64.32%
Sep 30, 2022 -69.01%
Jun 30, 2022 -87.76%
Mar 31, 2022 -64.27%
Dec 31, 2021 -45.84%
Sep 30, 2021 -57.59%
Jun 30, 2021 -43.42%